Vitamin D Supplementation for Deficiency (Level 12 ng/mL)
For a patient with a vitamin D level of 12 ng/mL, prescribe 50,000 IU of vitamin D3 (or D2) once weekly for 8 weeks, followed by maintenance therapy of 1,500-2,000 IU daily. 1
Treatment Rationale
Your patient has clear vitamin D deficiency (12 ng/mL is well below the target of ≥30 ng/mL). The Endocrine Society guideline provides the most authoritative dosing recommendation for this scenario 1. This regimen has been proven effective in correcting deficiency in adults, raising 25(OH)D levels above 30 ng/mL within 8 weeks.
Initial Repletion Phase (8 Weeks)
- Standard dose: 50,000 IU once weekly for 8 weeks
- Alternative daily equivalent: 6,000 IU daily for 8 weeks
- Both vitamin D2 (ergocalciferol) and D3 (cholecalciferol) are acceptable, though D3 is generally preferred for its superior pharmacological properties 2
Maintenance Phase (After 8 Weeks)
After completing the 8-week repletion:
- Standard maintenance: 1,500-2,000 IU daily 1
- This prevents recurrence of deficiency
- Alternative: 50,000 IU every other week has been shown effective in maintaining levels between 35-50 ng/mL 1
Special Considerations That May Require Dose Adjustment
If Patient is Obese (BMI ≥30)
- Increase repletion dose 2-3 times: Use 6,000-10,000 IU daily (or equivalent weekly dosing)
- Maintenance dose: At least 3,000-6,000 IU daily 1
- Obesity significantly impairs vitamin D absorption and metabolism; standard dosing often fails in these patients 3, 4
If Patient Has Malabsorption (Celiac, Crohn's, Cystic Fibrosis)
- Use the same higher dosing as for obesity: 6,000-10,000 IU daily
- Monitor response closely; if no increase in 25(OH)D after 8 weeks, consider workup for occult malabsorption 1
If Patient Takes Certain Medications
Anticonvulsants, glucocorticoids, or other drugs that activate steroid xenobiotic receptors destroy vitamin D:
- Require 2-3 times higher doses (6,000-10,000 IU daily) 1
Monitoring Strategy
- Recheck 25(OH)D level at 8-12 weeks to confirm achievement of target (≥30 ng/mL)
- If level remains <30 ng/mL despite compliance, consider:
- Obesity requiring higher dosing
- Malabsorption syndrome
- Medication interactions
- Non-compliance
Important Caveats
Do not use single massive doses (e.g., 300,000 IU at once). While some studies have explored this approach 5, 6, limited data suggest paradoxically increased fall and fracture risk with huge single doses 7. The weekly dosing protocol is safer and equally effective.
Calcium co-supplementation: Ensure adequate calcium intake (dietary or supplemental) for optimal response to vitamin D therapy 1. The guideline emphasizes that adequate dietary calcium is necessary for clinical response.
Avoid over-supplementation: Target 25(OH)D levels of 30-50 ng/mL. Levels >50-60 ng/mL may increase risks without additional benefit 7.
Why This Approach
The 50,000 IU weekly × 8 weeks protocol is supported by the highest quality guideline evidence 1 and has been validated in multiple studies showing consistent achievement of target levels 8, 9, 10. This dosing frequency optimizes compliance compared to daily regimens while avoiding the safety concerns of massive single doses. Research confirms that weekly, daily, or even monthly dosing of equivalent cumulative amounts produces similar steady-state levels 9, 10, but the weekly protocol balances efficacy, safety, and adherence.